通过定制设计的基于ZnFe2O4的纳米系统对瘤免疫治疗的cGAS/STING通路进行编程启动和增强
Jing Yang1, Yuping He1, Meng Zhang1
1Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China.
Exploration (Beijing, China)
|January 24, 2024
概括
一个新的纳米系统针对瘤细胞激活循环氨酸单酸-氨酸单酸合成酶 (cGAS) /干扰素基因刺激器 (STING) 途径. 这种方法通过促进免疫细胞活性和抑制瘤生长来增强抗癌免疫力.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 循环氨酸单酸-氨酸单酸合成酶 (cGAS) /干扰素基因刺激器 (STING) 途径对抗癌免疫非常重要.
- 在瘤细胞中合理激活和增强cGAS/STING通路仍然是有效免疫治疗的挑战.
研究的目的:
- 开发一种对谷氨敏感的基于ZnFe2O4的纳米系统,用于编程启动和增强瘤细胞中的STING信号通路.
- 为了研究这种纳米系统在癌症免疫治疗中与帕克利塔塞尔联合使用的疗效.
主要方法:
- 用癌细胞膜 (CCM) 涂覆的ZnFe2O4纳米颗粒的制造,用于有针对性的输送.
- 利用瘤细胞中的高谷氨水平触发纳米粒子分解并释放Fe3+和Zn2+离子.
- 研究释放的离子在刺激cGAS/STING通路和增强免疫反应中的作用.
主要成果:
- 该纳米系统成功向瘤细胞,并被谷氨分解,导致反应性氧物种生成和cGAS激活.
- Zn2+促进了cGAS-DNA相分离,增强了酶活性和STING通路信号.
- 组合治疗 (ZnFe2O4-PTX@CCM) 通过增加免疫细胞活性来抑制瘤的进展和复发.
结论:
- 开发的基于ZnFe2O4的纳米系统有效地激活瘤细胞中的cGAS/STING通路,为癌症免疫治疗提供了一个有前途的策略.
- 这种方法为构建STING激活纳米系统以增强抗瘤免疫力提供了可行的参考.
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


